688426 康为世纪
已收盘 08-25 15:00:00
资讯
新帖
简况
每周股票复盘：康为世纪（688426）获肺炎支原体检测试剂三类证
证券之星 · 08-23 02:18
每周股票复盘：康为世纪（688426）获肺炎支原体检测试剂三类证
康为世纪（688426）披露2026年限制性股票激励计划草案，8月20日股价上涨19.99%
证券之星 · 08-20
康为世纪（688426）披露2026年限制性股票激励计划草案，8月20日股价上涨19.99%
股市必读：康为世纪新发布《关于自愿披露肺炎支原体核酸及耐药突变位点检测试剂盒（荧光PCR法）获得三类医疗器械注册证的公告》
证券之星 · 08-20
股市必读：康为世纪新发布《关于自愿披露肺炎支原体核酸及耐药突变位点检测试剂盒（荧光PCR法）获得三类医疗器械注册证的公告》
康为世纪最新公告：子公司肺炎支原体检测试剂盒获三类医疗器械注册证
证券之星 · 08-18
康为世纪最新公告：子公司肺炎支原体检测试剂盒获三类医疗器械注册证
每周股票复盘：康为世纪（688426）股东大会通过超募资金补流议案
证券之星 · 07-05
每周股票复盘：康为世纪（688426）股东大会通过超募资金补流议案
每周股票复盘：康为世纪（688426）拟用4500万超募资金补流
证券之星 · 06-20
每周股票复盘：康为世纪（688426）拟用4500万超募资金补流
康为世纪（688426）披露拟使用4500万元超募资金永久补充流动资金，6月16日股价上涨0.73%
证券之星 · 06-16
康为世纪（688426）披露拟使用4500万元超募资金永久补充流动资金，6月16日股价上涨0.73%
股市必读：康为世纪（688426）今年截至6月2日累计跌幅已超25%
证券之星 · 06-03
股市必读：康为世纪（688426）今年截至6月2日累计跌幅已超25%
康为世纪(688426.SH)：艰难梭菌谷氨酸脱氢酶抗原及毒素检测试剂盒(酶联免疫层析法)获得医疗器械注册证
智通财经 · 05-27
康为世纪(688426.SH)：艰难梭菌谷氨酸脱氢酶抗原及毒素检测试剂盒(酶联免疫层析法)获得医疗器械注册证
股市必读：康为世纪（688426）今年截至5月26日累计跌幅已超20%
证券之星 · 05-27
股市必读：康为世纪（688426）今年截至5月26日累计跌幅已超20%
【私募调研记录】华夏未来调研康为世纪
证券之星 · 05-26
【私募调研记录】华夏未来调研康为世纪
康为世纪（688426）披露2025年年度股东会决议公告，5月22日股价上涨2.78%
证券之星 · 05-22
康为世纪（688426）披露2025年年度股东会决议公告，5月22日股价上涨2.78%
每周股票复盘：康为世纪（688426）2025年营收1.94亿增53.74%
证券之星 · 05-10
每周股票复盘：康为世纪（688426）2025年营收1.94亿增53.74%
康为世纪（688426）披露2025年年度股东会会议资料，5月8日股价上涨2.34%
证券之星 · 05-08
康为世纪（688426）披露2025年年度股东会会议资料，5月8日股价上涨2.34%
康为世纪（688426）披露部分董事、高管减持期满未减持结果公告，5月6日股价上涨2.11%
证券之星 · 05-06
康为世纪（688426）披露部分董事、高管减持期满未减持结果公告，5月6日股价上涨2.11%
每周股票复盘：康为世纪（688426）股东户数增14.98%，一季度收入增37.19%
证券之星 · 05-02
每周股票复盘：康为世纪（688426）股东户数增14.98%，一季度收入增37.19%
图解康为世纪一季报：第一季度单季净利润同比增长32.50%
证券之星 · 04-29
图解康为世纪一季报：第一季度单季净利润同比增长32.50%
康为世纪(688426)3月31日股东户数0.44万户，较上期增加14.98%
证券之星 · 04-29
康为世纪(688426)3月31日股东户数0.44万户，较上期增加14.98%
康为世纪(688426.SH)发布一季度业绩，归母净亏损1535万元
智通财经 · 04-29
康为世纪(688426.SH)发布一季度业绩，归母净亏损1535万元
康为世纪（688426）7380万股限售股将于4月27日解禁，占总股本65.6%
证券之星 · 04-27
康为世纪（688426）7380万股限售股将于4月27日解禁，占总股本65.6%
加载更多
公司概况
公司名称：
江苏康为世纪生物科技股份有限公司
所属行业：
医药制造业
上市日期：
2022-10-25
主营业务：
江苏康为世纪生物科技股份有限公司的主营业务是分子检测底层核心技术的自主研发。公司的主要产品是分子检测原料酶、核酸保存试剂、核酸提取纯化试剂以及分子诊断试剂盒。
发行价格：
48.98
{"stockData":{"symbol":"688426","market":"SH","secType":"STK","nameCN":"康为世纪","latestPrice":21.05,"timestamp":1787641200000,"preClose":21.22,"halted":0,"volume":2182702,"delay":0,"changeRate":-0.008,"floatShares":112000000,"shares":112000000,"eps":-0.8892,"marketStatus":"已收盘","change":-0.17,"latestTime":"08-25 15:00:00","open":20.95,"high":21.2,"low":20.62,"amount":45658200,"amplitude":0.0273,"askPrice":21.13,"askSize":20,"bidPrice":21.05,"bidSize":61,"shortable":0,"etf":0,"ttmEps":-0.8892,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787707800000},"marketStatusCode":5,"adr":0,"adjPreClose":21.22,"symbolType":"stock_kcb","openAndCloseTimeList":[[1787621400000,1787628600000],[1787634000000,1787641200000]],"highLimit":23.34,"lowLimit":19.1,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":112493716,"isCdr":false,"pbRate":1.77,"roa":"--","roe":"--","epsLYR":-0.977,"committee":0.595142,"marketValue":2368000000,"turnoverRate":0.0194,"status":1,"afterMarket":{"amount":0,"volume":0,"close":21.05,"buyVolume":9645,"sellVolume":0,"time":1787643237746,"indexStatus":"已收盘 08-25 15:30:00","preClose":21.22},"floatMarketCap":2362000000},"requestUrl":"/m/hq/s/688426","defaultTab":"news","newsList":[{"id":"2661114312","title":"每周股票复盘：康为世纪（688426）获肺炎支原体检测试剂三类证","url":"https://stock-news.laohu8.com/highlight/detail?id=2661114312","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661114312?lang=zh_cn&edition=full","pubTime":"2026-08-23 02:18","pubTimestamp":1787422692,"startTime":"0","endTime":"0","summary":"截至2026年8月21日收盘，康为世纪报收于22.42元，较上周的19.12元上涨17.26%。本周，康为世纪8月21日盘中最高价报23.39元。本周关注点公司公告汇总：肺炎支原体核酸及耐药突变位点检测试剂盒获Ⅲ类医疗器械注册证。本次获批进一步丰富了公司呼吸道病原体检测试剂产品管线，对公司未来经营发展具有积极影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082300000402.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688426"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660428002","title":"康为世纪（688426）披露2026年限制性股票激励计划草案，8月20日股价上涨19.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660428002","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660428002?lang=zh_cn&edition=full","pubTime":"2026-08-20 22:12","pubTimestamp":1787235139,"startTime":"0","endTime":"0","summary":"截至2026年8月20日收盘，康为世纪报收于22.87元，较前一交易日上涨19.99%，最新总市值为25.73亿元。该股当日开盘20.5元，最高22.87元，最低20.09元，成交额达4776.78万元，换手率为1.9%。近日，康为世纪发布《关于召开2026年第三次临时股东会的通知》，拟于2026年9月10日召开2026年第三次临时股东会，审议《2026年限制性股票激励计划（草案）》及其摘要、实施考核管理办法、授权董事会办理相关事宜等三项议案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082000045016.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688426","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660478849","title":"股市必读：康为世纪新发布《关于自愿披露肺炎支原体核酸及耐药突变位点检测试剂盒（荧光PCR法）获得三类医疗器械注册证的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2660478849","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660478849?lang=zh_cn&edition=full","pubTime":"2026-08-20 03:14","pubTimestamp":1787166852,"startTime":"0","endTime":"0","summary":"截至2026年8月19日收盘，康为世纪报收于19.06元，下跌1.35%，换手率1.04%，成交量1.16万手，成交额2232.79万元。公司公告汇总：全资子公司自主研发的肺炎支原体核酸及耐药突变位点检测试剂盒获国家药监局Ⅲ类医疗器械注册证，注册证编号国械注准20263401716，有效期至2031年8月16日。该产品用于体外定性检测人咽拭子样本中肺炎支原体DNA及其23S rRNA2063和2064耐药突变位点，可同步实现感染检测与耐药信息判读，辅助临床合理用药。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082000002762.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159883","BK0239","BK1583","BK1574","BK1100","688426","09996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660464571","title":"康为世纪最新公告：子公司肺炎支原体检测试剂盒获三类医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2660464571","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660464571?lang=zh_cn&edition=full","pubTime":"2026-08-18 19:19","pubTimestamp":1787051962,"startTime":"0","endTime":"0","summary":"康为世纪(688426.SH)公告称，公司全资子公司健为诊断自主研发的肺炎支原体核酸及耐药突变位点检测试剂盒(荧光PCR法)获国家药监局颁发的Ⅲ类医疗器械注册证。该产品可同步检测肺炎支原体感染及大环内酯类抗生素耐药突变位点，辅助指导临床合理用药。此次获证是公司在呼吸道疾病检测领域取得的第5张Ⅲ类注册证，进一步丰富产品管线，有望提升公司在呼吸道感染分子诊断市场的竞争力。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081800036714.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","09996","BK0239","BK1583","688426","BK1100","159883"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649924466","title":"每周股票复盘：康为世纪（688426）股东大会通过超募资金补流议案","url":"https://stock-news.laohu8.com/highlight/detail?id=2649924466","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649924466?lang=zh_cn&edition=full","pubTime":"2026-07-05 04:14","pubTimestamp":1783196051,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘，康为世纪报收于18.34元，较上周的19.11元下跌4.03%。本周，康为世纪6月29日盘中最高价报19.46元。本周关注点公司公告汇总：股东大会审议通过使用部分超募资金永久补充流动资金的议案，同意股数占比99.9297%。公司公告汇总上海市通力律师事务所就江苏康为世纪生物科技股份有限公司2026年第二次临时股东会的召集召开程序、出席人员资格、表决程序及表决结果出具法律意见。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070500001491.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688426"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644206630","title":"每周股票复盘：康为世纪（688426）拟用4500万超募资金补流","url":"https://stock-news.laohu8.com/highlight/detail?id=2644206630","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2644206630?lang=zh_cn&edition=full","pubTime":"2026-06-20 03:42","pubTimestamp":1781898134,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘，康为世纪报收于16.32元，较上周的16.88元下跌3.32%。本周，康为世纪6月15日盘中最高价报17.25元。6月18日盘中最低价报15.83元，股价触及近一年最低点。康为世纪当前最新总市值18.36亿元，在医疗器械板块市值排名125/129，在两市A股市值排名5081/5206。本周关注点公司公告汇总：康为世纪拟使用超募资金4,500.00万元永久补充流动资金。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062000002167.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688426"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643759371","title":"康为世纪（688426）披露拟使用4500万元超募资金永久补充流动资金，6月16日股价上涨0.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2643759371","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2643759371?lang=zh_cn&edition=full","pubTime":"2026-06-16 18:49","pubTimestamp":1781606951,"startTime":"0","endTime":"0","summary":"截至2026年6月16日收盘，康为世纪报收于16.5元，较前一交易日上涨0.73%，最新总市值为18.56亿元。该股当日开盘16.37元，最高16.65元，最低15.9元，成交额达1627.36万元，换手率为0.89%。近日，江苏康为世纪生物科技股份有限公司披露《2026年第二次临时股东会会议资料》，公告显示公司拟使用超募资金4,500.00万元永久补充流动资金，占超募资金总额15,508.19万元的29.02%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061600036619.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688426"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640253729","title":"股市必读：康为世纪（688426）今年截至6月2日累计跌幅已超25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640253729","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640253729?lang=zh_cn&edition=full","pubTime":"2026-06-03 04:18","pubTimestamp":1780431492,"startTime":"0","endTime":"0","summary":"截至2026年6月2日收盘，康为世纪报收于18.18元，下跌4.27%，换手率1.01%，成交量1.13万手，成交额2085.45万元。交易信息汇总股价提醒6月2日康为世纪收盘报18.18元，跌4.27%，当日成交2085.45万元。该股已连续7日下跌，当年累计跌幅27.48%。前10个交易日中，主力资金累计净流出507.18万元，股价累计下跌18.95%；融资余额累计增加70.75万元，融券余量累计增加0股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060300006503.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688426"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638577017","title":"康为世纪(688426.SH)：艰难梭菌谷氨酸脱氢酶抗原及毒素检测试剂盒(酶联免疫层析法)获得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2638577017","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2638577017?lang=zh_cn&edition=full","pubTime":"2026-05-27 15:59","pubTimestamp":1779868763,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康为世纪 发布公告，近日，公司全资子公司江苏健为诊断科技有限公司自主研发的艰难梭菌谷氨酸脱氢酶抗原及毒素检测试剂盒获得国家药品监督管理局颁发的Ⅲ类《医疗器械注册证》。健为诊断自主研发的消化道病原体检测产品“艰难梭菌谷氨酸脱氢酶抗原及毒素检测试剂盒”，采用免疫层析与酶联放大反应相结合技术，可在体外对粪便样本中的艰难梭菌谷氨酸脱氢酶及毒素A/B进行快速定性检测。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1446552.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09996","688426","BK0239","BK1574","BK1100","159883","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638542218","title":"股市必读：康为世纪（688426）今年截至5月26日累计跌幅已超20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638542218","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2638542218?lang=zh_cn&edition=full","pubTime":"2026-05-27 03:08","pubTimestamp":1779822494,"startTime":"0","endTime":"0","summary":"截至2026年5月26日收盘，康为世纪报收于19.58元，下跌4.11%，换手率1.49%，成交量1.67万手，成交额3305.29万元。交易信息汇总股价提醒5月26日康为世纪收盘报19.58元，跌4.11%，当日成交167.43万元。该股已连续3日下跌，当年累计跌幅20.35%。前10个交易日中，主力资金累计净流出866.82万元，股价累计下跌4.7%；融资余额累计增加120.86万元，融券余量累计增加0股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052700002364.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688426"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638026563","title":"【私募调研记录】华夏未来调研康为世纪","url":"https://stock-news.laohu8.com/highlight/detail?id=2638026563","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2638026563?lang=zh_cn&edition=full","pubTime":"2026-05-26 08:04","pubTimestamp":1779753898,"startTime":"0","endTime":"0","summary":"根据市场公开信息及5月25日披露的机构调研信息，知名私募华夏未来近期对1家上市公司进行了调研，相关名单如下：1）康为世纪 调研纪要：2025年度，公司实现营业收入19,352万元，同比增加53.74%，主要系基因测序、基因合成等科技服务业务的快速增长带来营业收入增长。2025年度研发费用7,737万元，同比减少22.03%，系优化研发资源配置、调整项目节奏所致。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2026052600004958.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688426","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637049318","title":"康为世纪（688426）披露2025年年度股东会决议公告，5月22日股价上涨2.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637049318","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2637049318?lang=zh_cn&edition=full","pubTime":"2026-05-22 18:02","pubTimestamp":1779444155,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘，康为世纪报收于20.72元，较前一交易日上涨2.78%，最新总市值为23.31亿元。公司于近日披露《2025年年度股东会决议公告》。公告显示，江苏康为世纪生物科技股份有限公司于2026年5月21日召开2025年年度股东会，会议由董事会召集，董事长王春香主持，采用现场与网络投票结合方式召开。出席会议股东共41人，代表有表决权股份76,768,215股，占公司有表决权总股本的69.8326%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052200035896.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688426"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634412577","title":"每周股票复盘：康为世纪（688426）2025年营收1.94亿增53.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2634412577","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2634412577?lang=zh_cn&edition=full","pubTime":"2026-05-10 03:23","pubTimestamp":1778354590,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，康为世纪报收于21.85元，较上周的20.84元上涨4.85%。本周，康为世纪5月8日盘中最高价报21.98元。来自业绩披露要点：2025年公司营收1.94亿元，同比增长53.74%。因净利润为负，2025年度拟不进行利润分配。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051000001347.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688426"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633293434","title":"康为世纪（688426）披露2025年年度股东会会议资料，5月8日股价上涨2.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633293434","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2633293434?lang=zh_cn&edition=full","pubTime":"2026-05-08 18:05","pubTimestamp":1778234716,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，康为世纪报收于21.85元，较前一交易日上涨2.34%，最新总市值为24.58亿元。该股当日开盘21.16元，最高21.98元，最低21.16元，成交额达2145.76万元，换手率为0.88%。近日，康为世纪发布2025年年度股东会会议资料。因净利润为负，2025年度拟不进行利润分配。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800032689.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688426","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633918106","title":"康为世纪（688426）披露部分董事、高管减持期满未减持结果公告，5月6日股价上涨2.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633918106","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2633918106?lang=zh_cn&edition=full","pubTime":"2026-05-06 18:44","pubTimestamp":1778064255,"startTime":"0","endTime":"0","summary":"截至2026年5月6日收盘，康为世纪报收于21.28元，较前一交易日上涨2.11%，最新总市值为23.94亿元。近日，江苏康为世纪生物科技股份有限公司发布《关于部分董事、高级管理人员减持期限届满未减持股份的结果公告》。截至2026年5月5日，减持期限届满，三人均未实施减持，当前持股数量及比例与减持计划披露前一致。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600032564.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688426"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632462587","title":"每周股票复盘：康为世纪（688426）股东户数增14.98%，一季度收入增37.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632462587","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2632462587?lang=zh_cn&edition=full","pubTime":"2026-05-02 06:42","pubTimestamp":1777675331,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，康为世纪报收于20.84元，较上周的19.47元上涨7.04%。本周，康为世纪4月30日盘中最高价报20.97元。业绩披露要点：一季度主营收入5899.73万元，同比上升37.19%。公司公告汇总：中信证券称康为世纪2025年度运作规范，未发现重大违规事项。股本股东变化股东户数变动截至2026年3月31日，康为世纪股东户数为4406.0户，较12月31日增加574.0户，增幅14.98%。户均持股数量由上期的2.94万股减少至2.55万股，户均持股市值为51.14万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200003634.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688426"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631949245","title":"图解康为世纪一季报：第一季度单季净利润同比增长32.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631949245","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2631949245?lang=zh_cn&edition=full","pubTime":"2026-04-29 18:22","pubTimestamp":1777458153,"startTime":"0","endTime":"0","summary":"证券之星消息，康为世纪2026年一季报显示，一季度公司主营收入5899.73万元，同比上升37.19%；归母净利润-1535.2万元，同比上升32.5%；扣非净利润-2058.1万元，同比上升28.47%；负债率8.69%，投资收益172.56万元，财务费用54.74万元，毛利率47.18%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900058779.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688426"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631596517","title":"康为世纪(688426)3月31日股东户数0.44万户，较上期增加14.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631596517","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2631596517?lang=zh_cn&edition=full","pubTime":"2026-04-29 17:43","pubTimestamp":1777455834,"startTime":"0","endTime":"0","summary":"证券之星消息，近日康为世纪披露，截至2026年3月31日公司股东户数为4406.0户，较12月31日增加574.0户，增幅为14.98%。在医疗器械行业个股中，康为世纪股东户数低于行业平均水平，截至3月31日，医疗器械行业平均股东户数为2.2万户。从股价来看，2025年12月31日至2026年3月31日，康为世纪区间跌幅为15.95%，在此期间股东户数增加574.0户，增幅为14.98%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900055473.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688426"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631562464","title":"康为世纪(688426.SH)发布一季度业绩，归母净亏损1535万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2631562464","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2631562464?lang=zh_cn&edition=full","pubTime":"2026-04-29 15:58","pubTimestamp":1777449521,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康为世纪(688426.SH)披露2026年第一季度报告，报告期公司实现营收5899.73万元，同比增长37.19%;归母净利润亏损1535万元;扣非净利润亏损2058万元。基本每股收益-0.14元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1436113.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"康为世纪(688426.SH)发布一季度业绩，归母净亏损1535万元","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688426","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630332484","title":"康为世纪（688426）7380万股限售股将于4月27日解禁，占总股本65.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630332484","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2630332484?lang=zh_cn&edition=full","pubTime":"2026-04-27 08:02","pubTimestamp":1777248142,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息整理，康为世纪于4月27日将有7380.0万股限售股份解禁，为公司追加承诺限售股份上市流通，占公司总股本65.6%。最近一年内，该股累计解禁43.42万股，占总股本的0.39%。本次解禁后，公司还有26.61万股限售股份，占总股本0.24%。康为世纪主营业务：分子检测底层核心技术的自主研发。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700007358.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688426"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1787666154407,"stockEarnings":[{"period":"1week","weight":0.1035},{"period":"1month","weight":0.4194},{"period":"3month","weight":0.0838},{"period":"6month","weight":-0.1665},{"period":"1year","weight":-0.1381},{"period":"ytd","weight":-0.1095}],"compareEarnings":[{"period":"1week","weight":-0.0253},{"period":"1month","weight":0.0178},{"period":"3month","weight":-0.0635},{"period":"6month","weight":-0.064},{"period":"1year","weight":0.0147},{"period":"ytd","weight":-0.0219}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"江苏康为世纪生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"4406人(较上一季度增加14.98%)","perCapita":"25471股","listingDate":"2022-10-25","address":"江苏省泰州市海陵区医药高新区泽兰路18号","registeredCapital":"11249万元","survey":" 江苏康为世纪生物科技股份有限公司的主营业务是分子检测底层核心技术的自主研发。公司的主要产品是分子检测原料酶、核酸保存试剂、核酸提取纯化试剂以及分子诊断试剂盒。","listedPrice":48.98},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康为世纪(688426)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康为世纪(688426)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康为世纪,688426,康为世纪股票,康为世纪股票老虎,康为世纪股票老虎国际,康为世纪行情,康为世纪股票行情,康为世纪股价,康为世纪股市,康为世纪股票价格,康为世纪股票交易,康为世纪股票购买,康为世纪股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康为世纪(688426)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康为世纪(688426)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}